Biogen reported $54.8M in Interest Expense on Debt for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
ALKERMES ALKS:US USD 4.77M 1.22M
Amgen AMGN:US USD 415M 47M
Biogen BIIB:US USD 54.8M 5.1M
Biomarin Pharmaceutical BMRN:US USD 3.63M 1.05M
Bristol Myers Squibb BMY:US USD 294M 5M
Esperion Therapeutics ESPR:US USD 14.33M 176K
Gilead Sciences GILD:US USD 227M 2M
Intercept Pharmaceuticals ICPT:US USD 2.81M 2.43M
Marinus Pharmaceuticals MRNS:US USD 3.69M 1.06M
Moderna Inc MRNA:US USD 10M 2M
Neurocrine Biosciences NBIX:US USD 1.1M 100K
Novartis NOVN:VX USD 219M 4M
Pfizer PFE:US USD 313M 2M
Ptc Therapeutics PTCT:US USD 25.9M 6.42M
Puma Biotechnology PBYI:US USD 3.28M 332K
Regeneron Pharmaceuticals REGN:US USD 17.4M 2.1M
Sarepta Therapeutics SRPT:US USD 6.69M 8.05M
Teva Pharmaceutical TEVA:IT USD 237M 7M
United Therapeutics UTHR:US USD 12.3M 3.1M
Vertex Pharmaceuticals VRTX:US USD 11.6M 2.1M
YTE INCY:US USD 667K 26K